Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction

This analysis reports on the outcomes of two different steroid sparing immunosuppression protocols used in the management of 120 highly sensitised patients (HSPs) with cRF>85% receiving Alemtuzumab induction, 53 maintained on tacrolimus (FK) monotherapy and 67 tacrolimus plus mycophenolate mofeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Eva, Spensley, Katrina, Gunby, Nicola, Clarke, Candice, Anand, Arthi, Roufosse, Candice, Willicombe, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272412/
https://www.ncbi.nlm.nih.gov/pubmed/37334011
http://dx.doi.org/10.3389/ti.2023.11056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272412/
https://www.ncbi.nlm.nih.gov/pubmed/37334011
http://dx.doi.org/10.3389/ti.2023.11056

Ejemplares similares